SYRE Spyre Therapeutics Inc.
Health Care, filed as SPYRE THERAPEUTICS INC (COM NEW), Equity Among managers we track Quote on Google Finance, opens in a new tab
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
Insider trades
Open-market buys and sales by SYRE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $401M sold by 2 insiders outside a trading plan
- $40.4M sold by 6 insiders under 10b5-1 plans
-
Heidy King-Jones See RemarksPlanned sale$2.6M 28,933 shares at $91.03 91% of stakeTraded Oct 1 Filed Oct 2
-
Cameron Turtle CEOPlanned sale$1.4M 15,000 shares at $92.01 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott L Burrows CFOPlanned sale$2.3M 25,000 shares at $90.47 24% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Heidy King-Jones See RemarksPlanned sale$2.5M 28,399 shares at $87.35 91% of stakeTraded Sep 1–2 Filed Sep 3
-
Scott L Burrows CFOPlanned sale$655K 7,500 shares at $87.31 7.1% of stakeTraded Sep 1 Filed Sep 3
-
Cameron Turtle CEOPlanned sale$1.3M 15,000 shares at $87.29 2.6% of stakeTraded Sep 1 Filed Sep 3
-
Jeffrey W. Albers DirectorPlanned sale$2.4M 23,000 shares at $104.53Traded Aug 7 Filed Aug 10
-
Scott L Burrows CFOPlanned sale$717K 7,500 shares at $95.57 7.1% of stakeTraded Aug 3 Filed Aug 5
-
Cameron Turtle CEOPlanned sale$1.4M 15,000 shares at $95.51 2.6% of stakeTraded Aug 3 Filed Aug 5
-
Scott L Burrows CFOPlanned sale$658K 7,500 shares at $87.74 7.1% of stakeTraded Jul 1 Filed Jul 2
-
Sheldon Sloan Chief Medical OfficerPlanned sale$731K 8,334 shares at $87.70 100% of stakeTraded Jul 1 Filed Jul 2
-
Cameron Turtle CEOPlanned sale$1.3M 15,000 shares at $87.69 2.5% of stakeTraded Jul 1 Filed Jul 2
-
Scott L Burrows CFOSale$1.3M 15,000 shares at $87.13 13% of stakeTraded Jun 25 Filed Jun 26
-
Michael Thomas Henderson DirectorPlanned sale$2M 20,000 shares at $100.00 23% of stakeTraded Jun 22 Filed Jun 23
-
Fairmount Funds Management LLC Director, +3 joint filersSale$400M 4,684,781 shares at $85.31 100% of stakeTraded Jun 23 Filed Jun 23
Also filed in the last 12 months, not counted as buying or selling: 18 option exercises, 1 conversion, 1 other transaction, and 1 sale to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 424B5 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $341.53M | $608.47M | $777.78M |
| Total non-current assets * | $331,000 | $10,000 | $0.00 |
| Total assets | $341.86M | $608.48M | $777.78M |
| Total current liabilities | $31.98M | $54.06M | $58.68M |
| Total non-current liabilities * | $41.31M | $36.62M | $3.86M |
| Total equity | $184.02M | $517.8M | $715.24M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon